Abuse and Misuse Cases

Part of our Verification, Validation, and regression testing series. For the full overview, start with V&V and Regression Testing for Medical Device Cybersecurity.

Medical devices do not fail only under idealized lab conditions. They fail when users enter bad data, when software receives something it did not expect, and when real-world behavior collides with design assumptions.

That is why abuse cases, misuse cases, malformed inputs, and unexpected inputs belong in the same test strategy. If you are building for patient safety and preparing for the FDA, this is not extra credit. It is part of the job.

Key Takeaways

• Abuse cases involve intentional actions beyond intended use.
• Misuse cases focus on unintentional user errors or environmental factors.
• Malformed inputs can cause crashes, data corruption, or unsafe therapy.
• Unexpected inputs expose hidden design assumptions and vulnerabilities.
• Strong testing requires scenario development from hazards and real workflows.
• Devices must be designed to fail safely, with early input validation.

Table of Contents

• Key Takeaways
• Abuse Cases, Misuse Cases, and Why the Difference Matters
• Malformed Inputs Are a Safety and Security Problem
• Unexpected Inputs Expose Bad Assumptions
• Building a Test Process That Finds Real Problems
• Designing Devices to Fail Safely
• Where Testing Is Going Next

Why this matters

The FDA's Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions (Feb 3, 2026 final guidance) made cybersecurity documentation a gating criterion for clearance under Section 524B of the FD&C Act. Reviewers now apply this guidance to abuse and misuse cases the same way they apply software lifecycle expectations from IEC 62304 and security risk-management expectations from AAMI TIR57 and ANSI/AAMI SW96:2023.

Gaps in this area are the single most common driver of first-cycle cybersecurity Additional Information (AI) requests. The FDA's FY2024 CDRH performance reports show cybersecurity is among the top deficiency categories cited in 510(k) and PMA AI letters, behind only software documentation and clinical evidence. Treating it as a checklist exercise rather than a design-controlled engineering artifact is what creates the gap.

Abuse Cases, Misuse Cases, and Why the Difference Matters

In medical device testing, “abuse” and “misuse” are related but not interchangeable. Both push a device outside normal operation. The difference is intent.

Abuse cases

Abuse cases involve intentional actions outside intended use that can stress, damage, or destabilize the device. A dropped monitor, a connector forced into the wrong port, repeated power cycling, or operation outside environmental limits all fit here.

These scenarios help manufacturers find design weaknesses before those weaknesses show up in the field. If a device is dropped from a realistic height, does it fail safely? If moisture exposure or heat affects a component, does the device degrade predictably or produce hazardous behavior? Those are not edge questions. They are practical ones.

Abuse testing should also include cyber-relevant behaviors. What happens when a system receives traffic at abnormal rates, malformed packets, or repeated authentication attempts? Even when the action is not part of intended clinical use, the device still needs a safe response.

Misuse cases

Misuse is usually unintentional. A clinician may configure a setting incorrectly. A patient may misunderstand an alert. A technician may connect accessories in the wrong order or enter values in the wrong units.

A familiar example is an infusion pump programmed with the wrong dose due to confusing workflow, poor input validation, or unclear UI design. In that case, the problem is not just user error. It is also a design and testing problem.

Misuse testing helps answer hard questions early:

• How easy is it to enter invalid values?
• Are unit conversions clear?
• Can a user recover from a mistake without creating risk?
• Does the device explain what went wrong in a way that supports safe action?

This is where cybersecurity and usability overlap. A device that handles user error poorly will often handle malformed software input poorly too.

Malformed Inputs Are a Safety and Security Problem

Testing against malformed inputs is basic engineering discipline. Users mistype values. Integrated systems send incomplete messages. Sensors drift. Interfaces receive out-of-range data. Attackers do all of that on purpose.

What can go wrong

A malformed input might be as simple as a negative dosage value, alphabetic characters in a numeric field, an oversized message, a truncated packet, or unexpected encoding. Any of those can trigger unsafe behavior if the software assumes inputs are always valid.

The consequences vary by device, but the pattern is familiar:

• incorrect therapy delivery
• device lockup or crash
• silent data corruption
• misleading alarms or missing alarms
• denial of service at the point of care

Too many teams treat this as a software quality issue only. It is not. If malformed input can affect therapy, alarms, logging, communications, or clinical decision support, it is a patient safety issue and a cybersecurity issue.

What good handling looks like

Safe devices do not just reject bad input. They reject it predictably, log it appropriately, preserve essential functions, and communicate clearly to the user or connected system.

That means testing for:

• boundary values
• type mismatches
• invalid ranges
• missing required fields
• duplicate or replayed messages
• truncated or fragmented communications
• corrupted files, firmware packages, or update metadata

If your device interoperates with other systems, this matters even more. Real environments are messy. Data arrives late, incomplete, out of order, or wrapped in assumptions your software team never intended to support.

Unexpected Inputs Expose Bad Assumptions

Unexpected input is not always malformed. Sometimes the data is technically valid but operationally surprising.

A monitoring device may receive a value sequence that is plausible in format but impossible physiologically. A sensor may produce noisy transitions during startup. A software update may change timing, field order, or error behavior in a connected component. These are the cases that often escape checklist testing.

Why this is hard

Unexpected inputs usually reveal hidden assumptions in the design:

• a value will arrive within a certain time window
• a sensor will fail in one known way
• a user will follow a single workflow
• an upstream system will always send complete data
• a field marked optional will almost never be empty

Those assumptions hold until they do not. Then the device does something unsafe, confusing, or both.

A good test program looks for these gaps on purpose. It does not stop at “valid” and “invalid.” It asks how the device behaves when reality gets strange but not impossible.

Practical ways to test for the unexpected

Manufacturers should build error handling into the design, then verify it under realistic stress. That may include visual alerts, audible alarms, haptic feedback, safe-state transitions, rate limiting, retry limits, or degraded modes that preserve essential safety functions.

It also means learning from actual use. Post-market data, complaint trends, support tickets, human factors findings, and field service observations should feed back into test case updates. If users keep finding a confusing path, or integrators keep sending odd traffic, that belongs in verification.

Collaboration matters here too. Engineers, clinicians, quality, regulatory, service teams, and security testers all see different failure modes. If only one group defines the test scenarios, blind spots are guaranteed.

Building a Test Process That Finds Real Problems

A useful abuse and misuse test process starts before formal verification. It begins with scenario development tied to hazards, architecture, interfaces, and real workflows.

Identify realistic scenarios

See also: Medical Device Open Box Testing, How curl Supports Medical Device Cybersecurity Testing, and Black-, Gray-, and White-Box Testing for Medical Devices.

Start with a structured “what could actually happen” exercise. Use prior failures, complaint data, threat modeling, human factors work, service records, and architecture review. Include abuse and misuse scenarios that span users, maintainers, connected systems, and adversarial behavior.

Tabletop exercises can help if they are done seriously. The goal is not brainstorming for its own sake. The goal is to identify conditions that could cause loss of essential performance, unsafe therapy, misleading information, or loss of availability.

Good scenarios often include combinations, not single errors. For example:

• a user enters an out-of-range value while network connectivity is unstable
• a device reboots during data synchronization
• a sensor fault coincides with an alarm acknowledgment
• a malformed network message arrives during a software update

That is where weak assumptions tend to surface.

Test across methods, not just one environment

Once scenarios are defined, test them with more than one method. Simulation is useful. Bench testing is useful. Fuzzing can be useful. Integrated system testing is useful. Realistic workflow testing with representative users is useful. None of them is enough alone.

For connected devices, malformed and unexpected input testing should include interface-level evaluation, not just UI fields. That means network protocols, APIs, wireless stacks, file imports, update paths, maintenance ports, and third-party integrations.

And yes, safety still comes first during testing. But “safe” should not mean “so constrained that nothing interesting happens.” If your process cannot expose unstable behavior, it is not telling you much.

Designing Devices to Fail Safely

You cannot test your way out of weak architecture. Devices need to be designed with failure handling in mind from the start.

Design principles that matter

Strong designs do a few things well:

• validate inputs early and often
• separate untrusted input from safety-critical logic
• apply sane bounds checking and type enforcement
• fail to a known safe state when needed
• preserve logs and forensic value
• provide clear, actionable user feedback
• prevent a single bad input from cascading through the system

For example, if a device detects a voltage anomaly, communication fault, or invalid command, it should not silently continue as if everything is fine. It should alert appropriately, contain the issue, and protect essential functions.

This is also where anti-checklist thinking matters. Saying “input validation implemented” is meaningless unless you can show how it behaves under stress, across interfaces, and in combinations of failure conditions.

Keep test cases alive after release

Testing does not stop at launch. User behavior changes. Clinical environments change. Connected ecosystems change. Threats change. The FDA expects post-market vigilance, and so should you.

Update test cases based on:

• field incidents and complaints
• security research and vulnerability disclosures
• software changes and new integrations
• human factors findings
• protocol and infrastructure changes in deployed environments

This feedback loop is not administrative overhead. It is how you keep a device safe and defensible over time.

Where Testing Is Going Next

The testing toolbox is improving, but the goal is still the same: find unsafe behavior before it reaches patients.

Better tools, same accountability

Automation, AI-assisted test generation, and machine learning can help teams cover more scenarios faster. They can surface strange combinations humans might miss. Virtual environments can also improve workflow and training validation before live evaluation.

Artificial intelligence and machine learning may speed up scenario generation, but they do not replace engineering judgment. Someone still has to decide what matters for safety, what constitutes acceptable behavior, and what evidence will stand up in design review or an FDA submission.

The same applies to connected care. As IoT (Internet of Things) functionality expands, test scope expands with it. More connectivity means more input paths, more dependencies, and more ways for malformed or unexpected data to create downstream risk.

Regulatory expectations are not standing still

As technology changes, regulatory expectations keep moving. Manufacturers need to track FDA guidance, understand what the FDA will expect in premarket documentation, and show that cybersecurity and safety testing are connected rather than siloed.

That includes evidence that abuse cases, misuse cases, malformed inputs, and interface failures were considered in a risk-based way. It also means being ready to explain why your test coverage reflects actual device behavior, not just a generic template.

Medical device testing gets better when it stops pretending users, environments, and integrated systems will behave perfectly. They will not. Devices need to handle the wrong input, the strange input, and the hostile input without creating unacceptable risk.

That takes disciplined engineering, realistic test design, and post-market follow-through. If your current process only proves the device works when everything goes right, it is not enough.

As you evaluate abuse cases, misuse cases, and malformed input handling, do not treat cybersecurity as a separate workstream. It is part of device safety, part of design validation, and part of what the FDA will expect to see when software behavior can affect clinical outcomes. Blue Goat Cyber helps manufacturers test the failure paths that matter, align evidence with FDA expectations, and improve device resilience before review or release. Contact us today for cybersecurity help.

How Blue Goat approaches this

Our approach to medical device testing for abuse and misuse cases focuses on identifying critical failure points and ensuring safe states. We employ a structured methodology, drawing on extensive experience in cybersecurity to simulate realistic threat scenarios and user errors. Our team, composed of professionals with CISSP and OSCP certifications, including former military red team members, understands how to uncover vulnerabilities that typical testing might miss. We implement a focused strategy for input validation and error handling, ensuring devices behave predictably under duress. This includes detailed analysis of data flows and interface interactions. We provide guidance through the regulatory submission process, specializing in addressing the stringent requirements of the FDA. Should the FDA raise cybersecurity deficiencies after our submission, we resolve them at no additional cost. We aim to identify and address complex issues early, reducing risk and accelerating market readiness. Learn more about our services at: /services/fda-premarket-cybersecurity-services.

FAQ

What is the difference between an abuse case and a misuse case in medical device testing?

An abuse case involves intentional actions outside the device's intended use, often stressing its limits or attempting to cause harm (e.g., cyberattack simulation, physical drops). A misuse case involves unintentional actions by a user or environmental factors that lead to incorrect operation (e.g., incorrect settings input, misinterpreting an alert).

Why are malformed inputs a safety and security problem for medical devices?

Malformed inputs, such as negative dosage values or oversized network packets, can cause medical devices to crash, deliver incorrect therapy, corrupt data silently, or become unresponsive. This poses direct patient safety risks and creates cybersecurity vulnerabilities that can be exploited by attackers.

How does the FDA view abuse and misuse testing for medical devices?

The FDA expects medical device manufacturers to consider and test for abuse, misuse, and cybersecurity vulnerabilities as part of their risk management and design validation processes. The February 3, 2026 final guidance emphasizes the need for devices to handle both intended and reasonably foreseeable unintended uses safely, including those related to cybersecurity.

What are some examples of unexpected inputs in medical device testing?

Unexpected inputs are not always malformed but are operationally surprising, revealing hidden design assumptions. Examples include a monitoring device receiving physiologically impossible but validly formatted data, a sensor producing noisy transitions during startup, or an upstream system sending data out of sequence.

How can manufacturers build a strong test process for abuse and misuse cases?

Manufacturers should start by identifying realistic scenarios based on prior failures, threat modeling, and human factors. They should test across various methods (simulation, bench testing, fuzzing), include interface-level evaluations for connected devices, and maintain an active feedback loop from post-market data and security research.

What design principles help devices fail safely when confronted with bad inputs?

Key design principles include validating inputs early and often, separating untrusted input from safety-critical logic, applying sane bounds checking, failing to a known safe state, preserving logs for forensics, and providing clear user feedback. These measures prevent single bad inputs from cascading into system-wide failures.

Related: The Rising Tide of Cyber Threats in Medical Devices: Understanding the Risks

About the author

Christian Espinosa, CISSP, Founder, Blue Goat Cyber. Christian leads a team focused exclusively on medical device cybersecurity for FDA premarket submissions and postmarket compliance. Read more about Christian.